Oxford, UK, Friday 28 July 2017 11.09 GMT
A meta-analysis of GAIA’s digital therapy for depression (deprexis) has been published in the latest issue of the peer-reviewed scientific journal Psychiatry Research. First-authored by Dr. Conal Twomey from the University College Dublin, the meta-analysis included 8 randomized controlled trials (RCTs) with more than 2400 patients. The results showed robust effectiveness of our therapy software, no publication bias, no difference between developer-led versus independent studies, and a low drop-out rate. Of note, the treatment effects were not confounded by therapeutic support, as is often the case in other studies. This meta-analysis not only confirms the effectiveness of our approach but also demonstrates our commitment to develop sustainable interventions that perform effectively and reliably over decades, not just in a few studies. Our growing portfolio showcases the expertise we have honed for more than two decades, as we have developed effective digital interventions for mood and anxiety disorders, neurological and autoimmune diseases, and many other conditions that require novel and effective treatment approaches. The meta-analysis is available at http://dx.doi.org/10.1016/j.psychres.2017.06.081
You can refuse the use of Google Analytics by clicking on the following link. An opt-out cookie will be set on the computer, which prevents the future collection of your data when visiting this website: Disable Google Analytics
Further information concerning the terms and conditions of use and data privacy can be found at http://www.google.com/analytics/terms/gb.html or at http://www.google.com/intl/en/analytics/privacyoverview.html.
Please note that on this website, Google Analytics code is supplemented by “gat._anonymizeIp();” to ensure an anonymized collection of IP addresses (so called IP-masking).